Filer Snapshot

Larry G. Edwards

CIK 0001733062. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Individual

Total filings

25

Latest filing

24 Aug 2022

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: Forms 3/4/5 owner position for LJPC. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Largest parsed holding

Populates from the latest parsed 13F information table.

Open holding

13D/G large stake

No recent parsed 13D/G stake row for this CIK.

Browse 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Source: SEC Forms 3/4/5

4 filed on 24 Aug 2022 for CIK 0001733062.

View source filing
Business address
C/O Tetraphase Pharmaceuticals, Inc., 480 Arsenal Street, Suite 110, Watertown, MA, 02472

Filer intelligence

What SEC filings say about Larry G. Edwards

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Quick read

  • Forms 3/4/5 show insider context for LJPC.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

Open
13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 2 rows

Officer, director, and 10% owner holdings or transactions.

Open

Forms 3/4/5 insider context

LJPC

22 Aug 2022 · Chief Executive Officer

INVA

22 Aug 2022 · CEO of La Jolla Pharmaceutical

Latest update

What changed recently for Larry G. Edwards

Ownership report updated

Latest ownership report period: 22 Aug 2022. Open the source-backed page to inspect the fresh filing or facts context.

Update date

26 Aug 2022

Page type

Ownership filings

Latest period

22 Aug 2022

Ownership context was refreshed from SEC Forms 3/4/5 filed on 26 Aug 2022.

SEC filing record

CIK 0001733062 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
25
First seen
18 May 2021
Latest filing
24 Aug 2022
Entity
Individual

Latest Filings

Showing the latest 12 of 25 SEC filings for Larry G. Edwards.

4

4 filing

Filing date
24 Aug 2022
Reporting date
22 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Apr 2022
Reporting date
14 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Apr 2022
Reporting date
31 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Mar 2022
Reporting date
15 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Mar 2022
Reporting date
28 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Feb 2022
Reporting date
15 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Feb 2022
Reporting date
31 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Jan 2022
Reporting date
14 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
14 Jan 2022
Reporting date
12 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Jan 2022
Reporting date
30 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Dec 2021
Reporting date
15 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Dec 2021
Reporting date
30 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .